Chapter, a Medicare navigation platform, announced on Thursday that it raised $100 million in Series E funding. The New York-based company’s AI platform compares health plans from every insurance carrier,
Oricell Lands $110M to Take Cell Therapy to New Territory in Cancer
Cell therapy has become an established treatment option for certain blood cancers, but solid tumors remain elusive. Oricell Therapeutics aims to bring cell therapy to solid tumors and it has
How TEFCA Is Speeding Up Disability Benefits Determinations at Hospitals
The workflow for Social Security disability benefits determination has historically been a slow one, with hospitals and patients often waiting months for records to be requested, collected and manually transferred
Know Your Patient: How Technology Can Help Health Care Providers Dramatically Improve One Key Aspect of the Patient Experience
Imagine you’re a business owner with a suggestion box in your store. Every week you gather those cards from the box and read through them. And week after week, two
Luminai Raises $38M With Cleveland Clinic Using Its AI for Hospital Operations
Another AI startup helping providers automate administrative processes picked up a significant round of capital on Thursday. San Francisco-based Luminai snagged $38 million in Series B funding, bringing its fundraising
Which Health Plans Rank Highest In Digital Experience?
Cigna Healthcare leads the way in digital experience among commercial health plans, while UPMC Health Plan ranks highest among Medicare Advantage plans, according to a new report from JD Power.
AI-Driven Precision Care is the Fix for Our Health System’s Failures
Every primary care physician knows the moment. A patient – say, a 60-year-old woman who suffers from heart failure and diabetes – is seeking treatment for a headache, fever, or
Insurers have Cut Prior Auth by 11% Following Commitments
In June of 2025, health plans made a series of commitments to improve prior authorization. On Tuesday, insurer advocacy organization AHIP and Blue Cross Blue Shield Association gave their first
Trial Failure in the Skin Does Not Dent Insmed Drug’s Potential in the Lungs
Insmed’s new drug, Brinsupri, is still projected to reach blockbuster status, but an inflammatory skin disorder is no longer in the picture following a mid-stage clinical trial failure in this
It’s Time to Put Guardrails on GLP-1 Compounding
If ever there was a time for federal regulators and lawmakers to ensure that all medications are safe, contain high-quality ingredients, and are held to rigorous production standards, it would









